prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a mediterranean cohort of hiv-infected patients

prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a mediterranean cohort of hiv-infected patients

;Patricia Echeverría;Pere Domingo;Josep-María Llibre;Mar Gutierrez;Gracia Mateo;Jordi Puig;Anna Bonjoch;Nuria Pérez-Alvarez;Guillem Sirera;Bonaventura Clotet;Eugenia Negredo
spectrochimica acta - part a: molecular and biomolecular spectroscopy 2014 Vol. 2014 pp. -
145
echeverra2014biomedprevalence

Abstract

Background. There are conflicting data on the prevalence of coronary events and the quality of the management of modifiable cardiovascular risk factors (CVRF) in HIV-infected patients. Methods. We performed a retrospective descriptive study to determine the prevalence of coronary events and to evaluate the management of CVRF in a Mediterranean cohort of 3760 HIV-1-infected patients from April 1983 through June 2011. Results. We identified 81 patients with a history of a coronary event (prevalence 2.15%); 83% of them suffered an acute myocardial infarction. At the time of the coronary event, CVRF were highly prevalent (60.5% hypertension, 48% dyslipidemia, and 16% diabetes mellitus). Other CVRF, such as smoking, hypertension, lack of exercise, and body mass index, were not routinely assessed. After the coronary event, a significant decrease in total cholesterol P=0.025 and LDL-cholesterol P=0.004 was observed. However, the percentage of patients who maintained LDL-cholesterol > 100 mg/dL remained stable (from 46% to 41%, P=0.103). Patients using protease inhibitors associated with a favorable lipid profile increased over time P=0.028. Conclusions. The prevalence of coronary events in our cohort is low. CVRF prevalence is high and their management is far from optimal. More aggressive interventions should be implemented to diminish cardiovascular risk in HIV-infected patients.

Keywords

Citation

ID: 163654
Ref Key: echeverra2014biomedprevalence
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
163654
Unique Identifier:
10.1155/2014/823058
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet